Nicole Wilson
Senior Administrative Assistant @ Debiopharm Innovation Fund
Lausanne, Switzerland
Nicole Wilson is a startup investor at Debiopharm Innovation Fund in Lausanne. Nicole Wilson
Last updated:
For AI agents: llms.txt
About Debiopharm Innovation Fund
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflowsolutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge & networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.
Debiopharm Innovation Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cedric Odje
Senior Investment Associate
|
|||
|
Nicole Wilson
Senior Administrative Assistant
|
|||
Tanja Dowe
Chief Executive Officer
|
|||
Thomas Gibbs
Director
|
|||
Vincent Lepreux
Investment Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
